Benjamin Graham fit · Defensive deep-value investing
Is Krystal Biotech, Inc. Common Stock (KRYS) a Benjamin Graham Stock?
Meets 3/7 Graham criteria — partially qualifies.
55/100
CMixed signals
3/7 criteria passed
Benjamin Graham's Criteria, Applied to KRYS
P/E ≤ 15
key—
P/B ≤ 1.5
key48.2x
Current ratio ≥ 2
10.1x
Debt / Equity ≤ 1
0.0x
How KRYS Scores on Other Strategies
Live Financial Snapshot
Market cap
$8.38B
P/E (TTM)
91.5x
ROIC (TTM)
6.43%
Gross margin
93.89%
Frequently Asked Questions
What is KRYS's Benjamin Graham fit score?
KRYS scores 55/100 on our Benjamin Graham fit engine — grade C. Meets 3/7 Graham criteria — partially qualifies.
Does Benjamin Graham actually own KRYS?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends KRYS.
How often is this score updated?
KRYS's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends KRYS.